Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synchronous laryngeal squamous cell carcinoma and papillary urothelial carcinoma of the bladder: a case report and literature review.

Created on 18 Oct 2026

Authors

Asmae Bali, Fatima Rezzoug, Hanan Bailal, Kaouthar Khater, Fadoua Jebrouni, Hind Chibani, Ouissam Al Jarroudi, Sami Aziz Brahmi, Said Afqir

Published in

Oxford medical case reports. Volume 2026. Issue 10. Pages omag193. Epub Oct 17, 2026.

Abstract

Synchronous primary malignancies are defined as two histologically distinct tumors arising in different anatomical sites within six months. Although tobacco exposure is a recognized shared carcinogenic factor, the coexistence of laryngeal squamous cell carcinoma and bladder urothelial carcinoma remains rare. We report the case of a 75-year-old man with a 40 pack-year smoking history who presented with progressive dysphonia. Imaging revealed a locally advanced laryngeal tumor and an incidental bladder lesion. Histopathological examination confirmed a well-differentiated laryngeal squamous cell carcinoma and a low-grade non-muscle-invasive papillary urothelial carcinoma of the bladder, fulfilling the Warren and Gates criteria for synchronous primary tumors. The patient underwent induction chemotherapy for laryngeal preservation and transurethral resection of the bladder tumor followed by surveillance. This case highlights the importance of systematic screening and multidisciplinary management in high-risk patients.

PMID:
42893278
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement